Aprepitant is a medication that falls under the class of NK1 (neurokinin-1) receptor antagonists. It is primarily used to prevent nausea and vomiting caused by cancer chemotherapy and, to some extent, postoperative nausea and vomiting. The drug works by blocking the effects of neurokinin, a substance in the brain that triggers nausea and vomiting.
